Corona Remedies IPO Allotment, GMP Highlights: After the IPO closed bidding, Corona Remedies will finalise the allotment of shares. Post that, investors can track refunds and demat credits.
The issue was opened for subscription on December 08 and closed on December 10. The company raised Rs 655 crore. The shares were priced in a band of Rs 1,008-1,062 each.
| Corona Remedies IPO | Key Details |
| Price Band | Rs 1,008-1,062 each |
| IPO Date | December 8-10 |
| GMP | 27% |
| IPO Allotment date | December 11 |
| Listing date | December 15 |
Corona Remedies IPO: Size and structure
The IPO is structured entirely as an offer for sale, meaning the company is not raising fresh capital. A total of 0.62 crore shares are being offered by existing shareholders. The company raised Rs 194.85 crore in the anchor round from 15 participants, including names like SBI Mutual Fund, ICICI Prudential Mutual Fund, Kotak Mahindra AMC, and Axis Mutual Fund.
Book running lead managers and registrar
JM Financial, IIFL Capital, and Kotak Capital are managing the IPO of Corona Remedies as book-running lead managers, while Bigshare Services has been appointed as the registrar.
Corona Remedies IPO Allotment Highlights: Check allotment status, refund details, GMP today, listing date, and price band
Corona Remedies IPO Allotment, GMP, Listing LIVE Updates: GMP at 28%
As per the latest update, the company's shares are trading in the unlisted markets at Rs 1,362. This indicates a premium of 28% on the upper price band of the shares.
However, it is important to note that GMP is an unofficial metric which can only give an estimate of the listing price. The actual listing price may differ based on market mood and conditions.
Corona Remedies IPO Allotment, GMP, Listing LIVE Updates: Important dates
The shares allotted to the successful bidders will be credited to their demat account by December 12. The initiation of the refunds will also take place on the same date. The company is expected to get listed on NSE and BSE by December 15
Corona Remedies IPO Allotment, GMP, Listing LIVE Updates: How to register?
To check the Corona Remedies IPO allotment status through the registrar, follow these steps:
– Visit the official website of KFin Technologies.
– From the dropdown menu, select ‘Corona Remedies’ as the IPO.
– Choose one of the identification options – PAN, Application Number, DP ID/Client ID, or Bank Account Number.
-Enter the required details and click Search to view your allotment status.
Corona Remedies IPO Allotment, GMP, Listing LIVE Updates: About the company
Incorporated on August 27, 2004, is an India-focused branded pharmaceutical formulation company engaged in developing, manufacturing, and marketing products across women’s healthcare, cardio-diabeto, pain management, urology, and other therapeutic areas.
Corona Remedies IPO Allotment, GMP, Listing LIVE Updates: Q1FY26 result details
For Q1FY26, the company's revenue from operations stood at Rs 347 crore. For the same quarter, the company's earnings before income. tax, depreciation, and amortisation stood at Rs 70 crore. The company's net profit margin was reported at 13.3%.
Corona Remedies IPO Allotment, GMP, Listing LIVE Updates: Manufacturing facilities
The company operates two manufacturing facilities one in Gujarat and other in Himachal Pradesh. It is also commissioning a hormone manufacturing facility in Gujarat, which is expected to begin its commercial operations from Q1 FY27. As per its RHP, the company’s facilities support a diverse range of pharmaceutical dosage and packaging forms including tablets, capsules, sachets, liquids, and drops.
Corona Remedies IPO Allotment, GMP, Listing LIVE Updates: Final subscription details
The IPO which closed for subscription yesterday, was subscribed 137.04 times. Here is a breakdown of the segments.
NII segment was subscribed 208.88x
QIB segment subscribed 278.52x
Retail segment subscribed 28.73x
Employee segment 14.72x
Corona Remedies IPO Allotment, GMP, Listing LIVE Updates: Choice give CRL SUBSCRIBE rating
"Recent acquisitions have strengthened its presence in key chronic segments and improved growth visibility. CRL’s IPM ranking has improved from 37th to 29th, reflecting rising scale and competitiveness," Choice brokerage said in its report.
While valuations appear fully priced, the company’s sustainable business model and long-term growth prospects support a “Subscribe for Long Term” rating for this issue, it added
Corona Remedies IPO Allotment, GMP, Listing LIVE Updates: GMP up 28%
As per the latest update, the company's shares are trading at Rs 1,353 in the unlisted markets. This indicates a premium of nearly 28% over the upper price band. The company has fixed the price band for shares between Rs 1,008-1,066.
However, it is important to note that GMP is an unofficial metric to determine the listing price of shares. It fluctuates based on market mood and sentiment.
Corona Remedies IPO Allotment, GMP, Listing LIVE Updates: Risk factors
The pharma company is vulnerable to several risks including high dependency on third-party manufacturers, general economic slowdown, statutory and legal risks, licensing permits, competition from other pharma companies like Torrent Pharma, Mankind Pharma, Abbott India etc.
Corona Remedies IPO Allotment, GMP, Listing LIVE Updates: Choice Brokerage on Corona Remedies
"At the upper end of the price band, CRL is valued at a P/E multiple of 43.5× (based on FY25 EPS of Rs. 24.4) and an EV/Sales multiple of 5.5×, which appears fully priced relative to its peers. The company has demonstrated consistent revenue and profit growth, supported by healthy margins," Choice said on Corona's IPO
Corona Remedies IPO Allotment, GMP, Listing LIVE Updates: Deven Choksey on company's growth rate
“Between FY23-25 , the revenue grew at a compounded annual growth rate (CAGR) of 18%. The company is targeting revenue CAGR of 20% in the next 2-3 years by undertaking 15-20 new launches every year” Deven Choksey Research saidn in its report.
In terms of capacity, it has expanded the Bhayla hormones facility. As a long-term strategy, it will enter the exports market and increase its revenue contribution to 5% by FY2, the firm added.
Corona Remedies IPO Allotment, GMP, Listing LIVE Updates: How to check via registrar
To check the Corona Remedies IPO allotment status through the registrar, follow these steps:
- Visit the official website of KFin Technologies.
- From the dropdown menu, select ‘Corona Remedies’ as the IPO.
- Choose one of the identification options - PAN, Application Number, DP ID/Client ID, or Bank Account Number.
-Enter the required details and click Search to view your allotment status.
To check your Corona Remedies IPO allotment status on the NSE website, follow these steps
Via NSE
- Visit the NSE IPO Application Tracking page.
- Click on ‘Equity and SME IPO Bid Details’.
- From the list, select ‘Corona Remedies’.
- Enter your application number and PAN.
- Click Submit to view your allotment status.
Also read: Steamhouse India IPO: 5 must-know details about Rs 425 crore issue
Corona Remedies IPO Allotment, GMP, Listing LIVE Updates: How to check IPO allotment status
To find out whether you have received an allotment in the Corona Remedies IPO, follow these steps:
Via BSE
- Go to the BSE IPO Allotment Status page.
- Select ‘Equity’ under Issue Type.
- From the dropdown list, choose ‘Corona Remedies’.
- Enter your application number or PAN.
- Tick the ‘I’m not a robot’ captcha box and click Search.
Corona Remedies IPO Allotment, GMP, Listing LIVE Updates: About the company
Incorporated on August 27, 2004, is an India-focused branded pharmaceutical formulation company engaged in developing, manufacturing, and marketing products across women’s healthcare, cardio-diabeto, pain management, urology, and other therapeutic areas.